These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

280 related articles for article (PubMed ID: 19786509)

  • 1. Absorption and disposition of ginsenosides after oral administration of Panax notoginseng extract to rats.
    Liu H; Yang J; Du F; Gao X; Ma X; Huang Y; Xu F; Niu W; Wang F; Mao Y; Sun Y; Lu T; Liu C; Zhang B; Li C
    Drug Metab Dispos; 2009 Dec; 37(12):2290-8. PubMed ID: 19786509
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combinatorial metabolism notably affects human systemic exposure to ginsenosides from orally administered extract of Panax notoginseng roots (Sanqi).
    Hu Z; Yang J; Cheng C; Huang Y; Du F; Wang F; Niu W; Xu F; Jiang R; Gao X; Li C
    Drug Metab Dispos; 2013 Jul; 41(7):1457-69. PubMed ID: 23649704
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vivo distribution and pharmacokinetics of multiple active components from Danshen and Sanqi and their combination via inner ear administration.
    Long W; Zhang SC; Wen L; Mu L; Yang F; Chen G
    J Ethnopharmacol; 2014 Oct; 156():199-208. PubMed ID: 25218322
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Difference in oral absorption of ginsenoside Rg1 between in vitro and in vivo models.
    Han M; Fang XL
    Acta Pharmacol Sin; 2006 Apr; 27(4):499-505. PubMed ID: 16539852
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combined Contribution of Increased Intestinal Permeability and Inhibited Deglycosylation of Ginsenoside Rb1 in the Intestinal Tract to the Enhancement of Ginsenoside Rb1 Exposure in Diabetic Rats after Oral Administration.
    Liu C; Hu M; Guo H; Zhang M; Zhang J; Li F; Zhong Z; Chen Y; Li Y; Xu P; Li J; Liu L; Liu X
    Drug Metab Dispos; 2015 Nov; 43(11):1702-10. PubMed ID: 26265741
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ginseng polysaccharides enhanced ginsenoside Rb1 and microbial metabolites exposure through enhancing intestinal absorption and affecting gut microbial metabolism.
    Shen H; Gao XJ; Li T; Jing WH; Han BL; Jia YM; Hu N; Yan ZX; Li SL; Yan R
    J Ethnopharmacol; 2018 Apr; 216():47-56. PubMed ID: 29366768
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Brain distribution pharmacokinetics and integrated pharmacokinetics of Panax Notoginsenoside R1, Ginsenosides Rg1, Rb1, Re and Rd in rats after intranasal administration of Panax Notoginseng Saponins assessed by UPLC/MS/MS.
    Guo Q; Li P; Wang Z; Cheng Y; Wu H; Yang B; Du S; Lu Y
    J Chromatogr B Analyt Technol Biomed Life Sci; 2014 Oct; 969():264-71. PubMed ID: 25203723
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Comparison between the characteristics of absorption and pharmacokinetic behavior of ginsenoside Rg1 and ginsenoside Rb, of Panax notoginseng saponins].
    Han M; Fu S; Fang XL
    Yao Xue Xue Bao; 2007 Aug; 42(8):849-53. PubMed ID: 17944233
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of intramuscular and intravenous pharmacokinetics of ginsenosides in humans after dosing XueShuanTong, a lyophilized extract of Panax notoginseng roots.
    Zhang HY; Niu W; Olaleye OE; Du FF; Wang FQ; Huang YH; Yuan L; Li YF; Liu GP; Xu F; Yang JL; Li C
    J Ethnopharmacol; 2020 May; 253():112658. PubMed ID: 32035876
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of compatible herbs on the pharmacokinetics of effective components of Panax notoginseng in Fufang Xueshuantong Capsule.
    Pang HH; Li MY; Wang Y; Tang MK; Ma CH; Huang JM
    J Zhejiang Univ Sci B; 2017 Apr.; 18(4):343-352. PubMed ID: 28378572
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gut microbiota in the pharmacokinetics and colonic deglycosylation metabolism of ginsenoside Rb1 in rats: Contrary effects of antimicrobials treatment and restraint stress.
    Kang A; Zhang S; Zhu D; Dong Y; Shan J; Xie T; Wen H; Di L
    Chem Biol Interact; 2016 Oct; 258():187-96. PubMed ID: 27613481
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intravenous formulation of Panax notoginseng root extract: human pharmacokinetics of ginsenosides and potential for perpetrating drug interactions.
    Pintusophon S; Niu W; Duan XN; Olaleye OE; Huang YH; Wang FQ; Li YF; Yang JL; Li C
    Acta Pharmacol Sin; 2019 Oct; 40(10):1351-1363. PubMed ID: 31358899
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Absorption, disposition, and pharmacokinetics of saponins from Chinese medicinal herbs: what do we know and what do we need to know more?
    Yu K; Chen F; Li C
    Curr Drug Metab; 2012 Jun; 13(5):577-98. PubMed ID: 22292787
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Mechanism of oral absorption of panaxnotoginseng saponins].
    Han M; Han LM; Wang QS; Bai ZH; Fang XL
    Yao Xue Xue Bao; 2006 Jun; 41(6):498-505. PubMed ID: 16927822
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Effects of combination of Salvia miltiorrhiza and Panax notoginseng on the pharmacokinetics of their major bioactive components in Beagle dog].
    Zhang SY; Song M; Lu JG; Hang TJ
    Yao Xue Xue Bao; 2010 Nov; 45(11):1433-9. PubMed ID: 21361045
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics of ginsenosides following repeated oral administration of red ginseng extract significantly differ between species of experimental animals.
    Jeon JH; Lee J; Choi MK; Song IS
    Arch Pharm Res; 2020 Dec; 43(12):1335-1346. PubMed ID: 33225388
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multiple circulating saponins from intravenous ShenMai inhibit OATP1Bs in vitro: potential joint precipitants of drug interactions.
    Olaleye OE; Niu W; Du FF; Wang FQ; Xu F; Pintusophon S; Lu JL; Yang JL; Li C
    Acta Pharmacol Sin; 2019 Jun; 40(6):833-849. PubMed ID: 30327544
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular mechanisms governing different pharmacokinetics of ginsenosides and potential for ginsenoside-perpetrated herb-drug interactions on OATP1B3.
    Jiang R; Dong J; Li X; Du F; Jia W; Xu F; Wang F; Yang J; Niu W; Li C
    Br J Pharmacol; 2015 Feb; 172(4):1059-73. PubMed ID: 25297453
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development and validation of an UFLC-MS/MS assay for the absolute quantitation of nine notoginsenosides in rat plasma: Application to the pharmacokinetic study of Panax Notoginseng Extract.
    Zhou L; Xing R; Xie L; Rao T; Wang Q; Ye W; Fu H; Xiao J; Shao Y; Kang D; Wang G; Liang Y
    J Chromatogr B Analyt Technol Biomed Life Sci; 2015 Jul; 995-996():46-53. PubMed ID: 26021851
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metabolite profiling and pharmacokinetics of herbal compounds following oral administration of a cardiovascular multi-herb medicine (Qishen yiqi pills) in rats.
    Zhang Y; Shi P; Yao H; Shao Q; Fan X
    Curr Drug Metab; 2012 Jun; 13(5):510-23. PubMed ID: 22292791
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.